Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer  Miguel.

Slides:



Advertisements
Similar presentations
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)
Advertisements

Vitamin D in chronic kidney disease Adriana Dusso, Ph.D, Esther A. González, MD, FACP, Kevin J. Martin, MB, B.Ch, FASN Best Practice & Research Clinical.
Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell,
Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /
Eribulin—A review of preclinical and clinical studies
Gastric cancer Critical Reviews in Oncology / Hematology
Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi 
Lipid metabolism and lung cancer
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer 
Exercise issues in older cancer survivors
Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review  Cloé Brami, Ting Bao, Gary Deng  Critical.
Novel targets in gastric and esophageal cancer
Critical Reviews in Oncology / Hematology
Nicoletta Colombo, Martin Gore 
Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: A roadside study  Trinidad Gómez-Talegón, Inmaculada.
Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions?  Séverine Guiu, Anita Wolfer, William Jacot, Pierre.
Volume 8, Issue 3, Pages (March 2007)
Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force  Silvio Monfardini,
The PSA Era is not Over for Prostate Cancer
Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis 
The case for wider use of recombinant factor VIII concentrates
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer  Sandro Pignata, Enrico.
Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature  Omar Abdel-Rahman,
Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey  Lazzaro Repetto  Critical.
Triplet (FOLFOXIRI) versus doublet (FOLFOX or FOLFIRI) backbone chemotherapy as first-line treatment of metastatic colorectal cancer: A systematic review.
Amy M. Lin, Charles J. Ryan, Eric J. Small 
Metastatic Castration-Resistant Prostate Cancer: Two Case Reports of Dramatic Response with Abiraterone Acetate in Patients Heavily Pretreated with Chemotherapy.
Steroid-related emphysematous cystitis in an EGFR-mutant patient with lung adenocarcinoma while on gefitinib treatment  Diego Marquez-Medina, Sanjay Popat 
Genistein: Its role in metabolic diseases and cancer
Jonathan P. Evans, Paul A. Sutton, Boleslaw K. Winiarski, Stephen W
Rituximab, fludarabine, and cyclophosphamide versus fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia: A systematic review.
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)  Giorgio Arcangeli,
Volume 64, Pages e1-e3 (January 2017)
Abhimanyu Ghose, Ria Kundu, Tahir Latif 
Critical Reviews in Oncology / Hematology
Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatment  Judith Maresch, Sebastian F. Schoppmann,
P. Therasse, S. Carbonnelle, J. Bogaerts 
Olfa Baroudi, Amel Benammar-elgaaied 
Clinically useful prognostic factors in acute myeloid leukemia
Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric.
Gwo Yaw Ho, Natasha Woodward, Jermaine I.G. Coward 
Critical Reviews in Oncology / Hematology
Primary renal carcinoid: Treatment and prognosis
Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario  Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello  Critical.
David Lorente, Karim Fizazi, Christopher Sweeney, Johann S. de Bono 
Volume 74, Issue 2, Pages (August 2018)
Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer  Olav Erich Yri, Trine Bjoro, Sophie D.
Volume 71, Issue 1, Pages 1-3 (January 2017)
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Volume 66, Issue 3, Pages (September 2014)
Laurent Boccon-Gibod  European Urology Supplements 
The PSA Era is not Over for Prostate Cancer
Leonard S. Marks, Jiaoti Huang  European Urology 
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 12, Issue 3, Pages (September 2006)
Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon.
The Importance of Testosterone Control in Prostate Cancer
A Recurrent Cause of Upper Gastrointestinal Bleeding: Gastritis Diagnoses Are Not All Trivial  Javier Martínez-González, Ana García García de Paredes,
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Challenges and Opportunities in Hormone-Resistant Prostate Cancer
Volume 75, Issue 3, Pages (March 2019)
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Recommendations for the management of patients with homozygous familial hypercholesterolaemia: Overview of a new European Atherosclerosis Society consensus.
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Telling it like it isn't: truth and lies in a post-9/11 world
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Skin cancer epidemic in a wireless world
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Anaphylaxis epidemiology in patients with and patients without asthma: A United Kingdom database review  Antonio González-Pérez, BPharm, MS, Zuleika Aponte,
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Presentation transcript:

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer  Miguel A. Climent, Josep Mª Piulats, Alfredo Sánchez-Hernández, José Ángel Arranz, Javier Cassinello, Jesús García-Donas, Aránzazu González del Alba, Luis León-Mateos, Begoña Mellado, Mª José Méndez-Vidal, Begoña Pérez-Valderrama  Critical Reviews in Oncology / Hematology  Volume 83, Issue 3, Pages 341-352 (September 2012) DOI: 10.1016/j.critrevonc.2012.01.002 Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions

Fig. 1 Treatment algorithm for patients with metastatic castration-resistant prostate cancer. CT: chemotherapy; PSA: prostate-specific antigen. *Not approved for use by the European Medicines Agency. Critical Reviews in Oncology / Hematology 2012 83, 341-352DOI: (10.1016/j.critrevonc.2012.01.002) Copyright © 2012 Elsevier Ireland Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.